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1. INTRODUCTION {#ags312033-sec-0001}
===============

In sphincter‐preserving surgery for low rectal cancer, a diverting stoma is concomitantly formed with the aim of resting the anastomosis region until it heals.[1](#ags312033-bib-0001){ref-type="ref"}, [2](#ags312033-bib-0002){ref-type="ref"} Diverting stoma formation is recommended based on a meta‐analysis showing that this procedure reduced anastomotic leakage after low anastomosis close to the anus.[3](#ags312033-bib-0003){ref-type="ref"} However, in a multicenter study in Japan, prevention of anastomotic leakage by a diverting stoma after low anastomosis following rectal cancer resection was not found.[4](#ags312033-bib-0004){ref-type="ref"} Anal function is retained without a diverting stoma in some cases, and such patients thus undergo unnecessary stoma formation.[5](#ags312033-bib-0005){ref-type="ref"}, [6](#ags312033-bib-0006){ref-type="ref"}

Our department has carried out sphincter‐preserving surgery without a diverting stoma after low anterior resection (LAR) and intersphincteric resection (ISR) for low rectal cancer as a basic treatment strategy.[6](#ags312033-bib-0006){ref-type="ref"}, [7](#ags312033-bib-0007){ref-type="ref"} The objective of this retrospective study was to investigate safety, permanent stoma formation, and defecation function in patients who underwent this procedure for low rectal cancer, and to clarify the validity and indication for this treatment.

2. METHODS {#ags312033-sec-0002}
==========

2.1. Patients {#ags312033-sec-0003}
-------------

Of 370 consecutive patients with low rectal adenocarcinoma who underwent initial proctectomy at the Department of Gastroenterological Surgery, Hirosaki University, between 2000 and 2012, 298 received sphincter‐preserving surgery. Subjects of the present study were 275 of these patients, excluding one case with concomitant ulcerative colitis and 22 patients in whom a diverting stoma was formed after preoperative radiotherapy. Rectal cancer in which the lower margin was located below the peritoneal reflection during surgery was defined as low rectal cancer. Data for anastomotic leakage and perioperative complications, permanent stoma formation, and reasons for the procedure were collected from medical records. Perioperative complications were defined using the Clavien‐Dindo classification.[8](#ags312033-bib-0008){ref-type="ref"} Clinical leakage signs were defined as abdominal pain, abdominal distention, fever, and pus or fecal discharge from the pelvic drain. All clinically suspicious symptoms were confirmed by digital rectal examination and radiographic examination (e.g. extravasation of endoluminally given water‐soluble contrast enema, pelvic abscess and fluid/air bubbles surrounding the anastomosis on computed tomography).[7](#ags312033-bib-0007){ref-type="ref"} Using the proposed grading system, anastomotic leakage was classified into three grades: grade A required no active therapeutic intervention; grade B required active therapeutic intervention; and grade C required reoperation.[9](#ags312033-bib-0009){ref-type="ref"} Anastomotic leakage with grades B and C (but not grade A) within 30 days after surgery was defined as anastomotic leakage. Age, sex, body mass index (BMI), ischemic disease, diabetes, American Society of Anesthesiologists (ASA) status, intraoperative blood transfusion, tumor diameter, tumor‐anal verge distance, anastomotic height from anal verge, circumferential occupation, tumor depth, regional lymph node metastasis, distant metastasis, circumferential margin (CRM), operation time, blood loss, laparoscopy, combined resection, lateral lymph node dissection (LLND), resection procedure, and anastomosis method were examined as clinicopathological factors. When a stoma was present at final follow up, it was regarded as a permanent stoma.[10](#ags312033-bib-0010){ref-type="ref"} Median follow‐up period was 4.9 years.

2.2. Operative and perioperative management {#ags312033-sec-0004}
-------------------------------------------

In standard perioperative management, the patient fasted from the day before surgery, and received mechanical pretreatment and perioperative antibiotics before surgery and for 3 days after surgery. After pressure reduction by transanal drainage for about 1 week after surgery, food ingestion was started. After transection of the inferior mesenteric artery and vein, total mesorectal excision (TME) was carried out as a standard surgical procedure, and bilateral LLND was done when the depth was T3 or deeper, as a rule.[11](#ags312033-bib-0011){ref-type="ref"} To secure a 2‐cm resection margin, ISR was selected for tumors located within 2 cm from the upper margin of the levator ani muscle attachment region.[7](#ags312033-bib-0007){ref-type="ref"}, [8](#ags312033-bib-0008){ref-type="ref"}, [12](#ags312033-bib-0012){ref-type="ref"} For anastomosis in LAR and ISR, double‐stapled and hand‐sewn coloanal anastomosis were carried out, respectively. Side‐to‐end anastomosis was applied as a rule, and end‐to‐end anastomosis was used when the pelvis was narrow or the reconstructed intestine was short. When anastomotic leakage was clinically suspected after surgery, its presence or absence was confirmed by fluoroscopy or computed tomography (CT). If anastomotic leakage was observed, it was treated with antibiotics, a drainage tube, or stoma formation, depending on the details in each case. In approximately 6 months after stoma formation as a result of leakage, integrity of the anastomosis was checked by digital rectal examination and a water‐soluble contrast enema examination. Patients without any findings of anastomotic leakage underwent stoma closure. When findings of anastomotic leakage were sustained and the anastomosis was not expected to heal, stoma was not closed or permanent colostomy was formed. When patients had poor general condition such as unresectable distant metastases or dementia, stoma was not closed permanently even if integrity of the anastomosis was recovered.

2.3. Evaluation of function {#ags312033-sec-0005}
---------------------------

Defecation function and quality of life (QOL) were surveyed using a questionnaire in patients who did and did not develop anastomotic leakage, and evaluated based on the frequency of defecation per day and the Wexner Score[13](#ags312033-bib-0013){ref-type="ref"} and modified fecal incontinence quality of life (mFIQL) score.[14](#ags312033-bib-0014){ref-type="ref"}

2.4. Statistical analyses {#ags312033-sec-0006}
-------------------------

Risk factors for permanent stoma formation and for anastomotic leakage were analyzed by Fisher exact test. Factors with a significant difference were subjected to multivariate logistic regression analysis. Defecation function was compared between groups by Mann‐Whitney *U*‐test. Two‐sided *P*\<0.05 was regarded as significant. Statistical analysis was carried out using EZR.[15](#ags312033-bib-0015){ref-type="ref"}

3. RESULTS {#ags312033-sec-0007}
==========

3.1. Background of patients and complications {#ags312033-sec-0008}
---------------------------------------------

Median age was 64 years old (interquartile range, IQR: 55‐71.5), 199 patients (72.4%) were male, and median BMI was 22.7 (IQR: 20.8‐24.5). Fourteen patients (5.1%) had concomitant cerebral and cardiovascular lesions, 40 (14.5%) had diabetes, 30 (10.9%) had severe complications of ASA grade 3 or 4 or higher, and nine (3.3%) received blood transfusion during surgery. Median tumor diameter was 4.5 cm (IQR: 3.0‐6.1), median tumor‐anal verge distance was 4.5 cm (IQR: 3.0‐6.0), and the tumor was circumferential in 46 cases (16.7%). Disease stage was 0 in 10 cases (3.6%), I in 72 (26.2%), II in 60 (21.8%), III in 101 (36.7%), and IV in 32 (11.6%). LAR was carried out in 157 patients (57%) and ISR was carried out in 118 (43%). Laparoscopic surgery was carried out in eight patients (2.9%), combined resection of other organs in 18 (6.5%), LLND in 167 (60.7%), and side‐to‐end anastomosis in 222 (80.7%). Median operative time was 169 (138‐238) minutes, and median blood loss was 360 mL (180‐628). CRM was positive in seven patients (2.5%). Surgery‐related death occurred in one male patient as a result of anastomotic leakage after LAR. Clavien‐Dindo classification was III or higher in 72 cases (26.2%), and respiratory or dialysis management in an intensive care unit was necessary in six (2.2%). Anastomotic leakage of grades B and C occurred in 30 patients each (rates of 10.9% each) and the overall incidence was 21.8% (60/275) (Table [1](#ags312033-tbl-0001){ref-type="table-wrap"}).

###### 

Clinicopathological characteristics of 275 patients who underwent sphincter‐preserving surgery for low rectal cancer between 2000 and 2012

  Variable                                                                          Value
  --------------------------------------------------------------------------------- ------------------
  Age (y)                                                                           64 (55‐71.5)
  Gender, n (%)                                                                     
  Male                                                                              199 (72.4)
  Female                                                                            76 (27.6)
  Body mass index (kg/m^2^)[a](#ags312033-note-0001){ref-type="fn"}                 22.7 (20.8‐24.5)
  Ischemic disease, n (%)                                                           14 (5.1)
  Diabetes, n (%)                                                                   40 (14.5)
  ASA 3‐4, n (%)                                                                    30 (10.9)
  Blood transfusion, n (%)                                                          9 (3.3)
  Tumor size (cm)[a](#ags312033-note-0001){ref-type="fn"}                           4.5 (3.0‐6.1)
  Distance from anal verge to tumor (cm)[a](#ags312033-note-0001){ref-type="fn"}    4.5 (3.0‐6.0)
  Anastomotic height from anal verge (cm)[a](#ags312033-note-0001){ref-type="fn"}   3.0 (1.5‐4.0)
  Circumferential occupation, n (%)                                                 46 (16.7)
  Pathological TNM stage, n (%)                                                     
  0                                                                                 10 (3.6)
  I                                                                                 72 (26.2)
  II                                                                                60 (21.8)
  III                                                                               101 (36.7)
  IV                                                                                32 (11.6)
  Type of resection, n (%)                                                          
  Low anterior resection                                                            157 (57.1)
  Intersphincteric resection                                                        118 (42.9)
  Laparoscope‐assisted surgery, n (%)                                               8 (2.9)
  Combined resection, n (%)                                                         18 (6.5)
  Lateral lymph node dissection, n (%)                                              167 (60.7)
  Side to end anastomosis, n (%)                                                    222 (80.7)
  Operation time (min)[a](#ags312033-note-0001){ref-type="fn"}                      169 (138‐238)
  Blood loss (mL)[a](#ags312033-note-0001){ref-type="fn"}                           360 (180‐628)
  CRM positive, n (%)                                                               7 (2.5)
  Complications (Clavien‐Dindo), n (%)                                              
  All (I‐V)                                                                         135 (49.1)
  III                                                                               66 (24.0)
  IV                                                                                6 (2.2)
  V                                                                                 1 (0.45)
  Anastomotic leakage, n (%)                                                        
  Grade B                                                                           30 (10.9)
  Grade C                                                                           30 (10.9)

Median (interquartile range).

ASA, American Society of Anesthesiologists; CRM, circumferential margin.

John Wiley & Sons, Ltd

3.2. Risk factors for permanent stoma formation {#ags312033-sec-0009}
-----------------------------------------------

Five‐year cumulative permanent stoma formation rate was 16.7% in a median follow‐up period of 4.9 years (Figure [1](#ags312033-fig-0001){ref-type="fig"}). Reason for permanent stoma was poor healing of anastomotic leakage in 16 patients (35.5%), metastatic disease after anastomotic leakage in three (6.7%), delayed onset of anastomotic leakage in four (8.9%), local recurrence in 19 (42.2%), poor defecation function in two (4.4%), and perforation of sigmoid colon as a result of radiation therapy for bone metastasis in one (2.2%). Delayed onset of anastomotic leakage occurred between 2 months and 8 years after surgery. All resulted in the status of permanent stoma because of dementia in one male and one female, metastatic disease in one man, and poor healing of anastomotic leakage in one male. In univariate analysis, tumor‐anal verge distance \<5 cm, ISR, end‐to‐end anastomosis, and anastomotic leakage were identified as significant risk factors, and anastomotic leakage was an independent risk factor for permanent stoma formation in multivariate analysis (odds ratio (OR): 5.86, *P*\<0.001) (Table [2](#ags312033-tbl-0002){ref-type="table-wrap"}).

![Incidence of permanent stoma formation after sphincter‐preserving surgery without a diverting stoma for low rectal cancer](AGS3-2-79-g001){#ags312033-fig-0001}

###### 

Univariate and multivariate analyses of the dependence of permanent stoma on clinicopathological variables

  Variables                         n     Univariate analysis   Multivariate analysis                       
  --------------------------------- ----- --------------------- ----------------------- ------------------- ---------
  Age (y)                                                                                                   
  ≥65                               132   16 (12.1)             0.074                                       
  \<65                              143   29 (20.3)                                                         
  Gender                                                                                                    
  Female                            76    10 (13.2)             0.467                                       
  Male                              199   35 (17.6)                                                         
  Body mass index (kg/m^2^)                                                                                 
  \<25                              214   35 (16.4)             1                                           
  ≥25                               61    10 (16.4)                                                         
  Ischemic disease                                                                                          
  No                                261   43 (16.5)             1                                           
  Yes                               14    2 (14.3)                                                          
  Diabetes                                                                                                  
  No                                235   40 (17.0)             0.644                                       
  Yes                               40    5 (12.5)                                                          
  ASA                                                                                                       
  1, 2                              245   40 (16.3)             1                                           
  3, 4                              30    5 (16.7)                                                          
  Blood transfusion                                                                                         
  No                                266   42 (15.8)             0.168                                       
  Yes                               9     3 (33.3)                                                          
  Tumor size (cm)                                                                                           
  \<5                               157   20 (12.7)             0.070                                       
  ≥5                                118   25 (21.2)                                                         
  Tumor location from AV (cm)                                                                               
  ≥5                                137   16 (11.7)             0.049                   1.98 (0,86‐4.53)    0.107
  \<5                               138   29 (21.0)                                                         
  Anastomotic height from AV (cm)                                                                           
  \>4                               56    5 (8.9)               0.107                                       
  ≤4                                219   40 (18.3)                                                         
  Circumferential occupation                                                                                
  No                                229   36 (15.7)             0.516                                       
  Yes                               46    9 (19.6)                                                          
  Tumor depth                                                                                               
  T1, T2                            106   15 (14.2)             0.504                                       
  T3, T4                            169   30 (17.8)                                                         
  Regional lymph node metastasis                                                                            
  No                                146   21 (14.4)             0.415                                       
  Yes                               129   24 (18.6)                                                         
  Distant metastasis                                                                                        
  No                                243   42 (17.3)             0.318                                       
  Yes                               32    3 (9.4)                                                           
  CRM                                                                                                       
  Negative                          268   44 (16.4)             1                                           
  Positive                          7     1 (14.3)                                                          
  Operation time (min)                                                                                      
  \<160                             113   18 (15.9)             1                                           
  ≥160                              162   27 (16.7)                                                         
  Blood loss (mL)                                                                                           
  \<360                             136   21 (15.4)             0.746                                       
  ≥360                              139   24 (17.3)                                                         
  Laparoscopy                                                                                               
  No                                267   44 (16.5)             1                                           
  Yes                               8     1 (12.5)                                                          
  Combined resection                                                                                        
  No                                257   39 (15.2)             0.09                                        
  Yes                               18    6 (33.3)                                                          
  Lateral lymph node dissection                                                                             
  No                                108   12 (11.1)             0.067                                       
  Yes                               167   33 (19.8)                                                         
  Type of resection                                                                                         
  LAR                               157   19 (12.1)             0.032                   1.43 (0.56‐3.63)    0.456
  ISR                               118   26 (22.0)                                                         
  Side to end anastomosis                                                                                   
  No                                53    15 (28.3)             0.012                   0.62 (0.24‐1.60)    0.332
  Yes                               222   30 (13.5)                                                         
  Anastomotic leakage                                                                                       
  No                                215   23 (10.7)             \<0.001                 5.86 (2.82‐12.20)   \<0.001
  Yes                               60    22 (36.7)                                                         

ASA, American Society of Anesthesiologists; AV, distance from anal verge to tumor; CI, confidence interval; CRM, circumferential resection margin; ISR, intersphincteric resection; LAR, low anterior resection.

John Wiley & Sons, Ltd

3.3. Risk factors for anastomotic leakage {#ags312033-sec-0010}
-----------------------------------------

Age \<65 years old and male gender were significant risk factors for anastomotic leakage in univariate analysis, and were also independent risk factors in multivariate analysis (age \<65 years old: OR=1.99, *P*=0.001; male: OR=4.36, *P*=0.026) (Table [3](#ags312033-tbl-0003){ref-type="table-wrap"}). After development of anastomotic leakage, a permanent stoma was formed as a result of poor healing of anastomotic leakage in 29.6% of males (about one in three patients), regardless of age. In contrast, no permanent stoma as a result of poor healing of anastomotic leakage formed in females, regardless of age (Table [4](#ags312033-tbl-0004){ref-type="table-wrap"}).

###### 

Univariate and multivariate analyses of the dependence of anastomotic leakage on clinicopathological variables

  Variables                         n     Univariate analysis   Multivariate analysis                       
  --------------------------------- ----- --------------------- ----------------------- ------------------- -------
  Age                                                                                                       
  ≥65                               132   21 (15.9)             0.028                   1.99 (1.09‐3.65)    0.026
  \<65                              143   39 (27.3)                                                         
  Gender                                                                                                    
  Female                            76    6 (7.9)               \<0.001                 4.36 (1.78‐10.70)   0.001
  Male                              199   54 (27.1)                                                         
  Body mass index (kg/m^2^)                                                                                 
  \<25                              214   41 (19.2)             0.053                                       
  ≥25                               61    19 (31.1)                                                         
  Ischemic disease                                                                                          
  No                                261   57 (21.8)             1                                           
  Yes                               14    3 (21.4)                                                          
  Diabetes                                                                                                  
  No                                235   48 (20.4)             0.213                                       
  Yes                               40    12 (30.0)                                                         
  ASA                                                                                                       
  1, 2                              245   51 (20.8)             0.248                                       
  3, 4                              30    9 (30.0)                                                          
  Blood transfusion                                                                                         
  No                                266   58 (21.8)             1                                           
  Yes                               9     2 (22.2)                                                          
  Tumor size (cm)                                                                                           
  \<5                               157   30 (19.1)             0.239                                       
  ≥5                                118   30 (25.4)                                                         
  Tumor location from AV (cm)                                                                               
  ≥5                                137   36 (26.3)             0.081                                       
  \<5                               138   24 (17,4)                                                         
  Anastomotic height from AV (cm)                                                                           
  \>4                               56    12 (21.4)             1                                           
  ≤4                                219   48 (21.9)                                                         
  Circumferential occupation                                                                                
  No                                229   48 (21.0)             0.439                                       
  Yes                               46    12 (26.1)                                                         
  Tumor depth                                                                                               
  T1, T2                            106   22 (20.8)             0.766                                       
  T3, T4                            169   38 (22.5)                                                         
  Regional lymph node metastasis                                                                            
  No                                146   30 (20.5)             0.661                                       
  Yes                               129   30 (23.3)                                                         
  Distant metastasis                                                                                        
  No                                243   54 (22.2)             0.821                                       
  Yes                               32    6 (18.8)                                                          
  CRM                                                                                                       
  Negative                          268   59 (22.0)             1                                           
  Positive                          7     1 (14.3)                                                          
  Operation time (min)                                                                                      
  \<160                             113   29 (25.7)             0.235                                       
  ≥160                              162   31 (19.1)                                                         
  Blood loss (mL)                                                                                           
  \<360                             136   27 (19.9)             0.468                                       
  ≥360                              139   33 (23.7)                                                         
  Laparoscopy                                                                                               
  No                                267   60 (22.5)             0.207                                       
  Yes                               8     0 (0.0)                                                           
  Combined resection                                                                                        
  No                                257   57 (22.2)             0.771                                       
  Yes                               18    3 (16.7)                                                          
  Lateral lymph node dissection                                                                             
  No                                108   25 (23.1)             0.765                                       
  Yes                               167   35 (21.0)                                                         
  Type of resection                                                                                         
  LAR                               157   38 (24.2)             0.303                                       
  ISR                               118   22 (18.6)                                                         
  Side‐to‐end anastomosis                                                                                   
  No                                53    13 (24.5)             0.583                                       
  Yes                               222   47 (21.2)                                                         

ASA, American Society of Anesthesiologists; AV, distance from anal verge to tumor; CI, confidence interval; CRM, circumferential resection margin; ISR, intersphincteric resection; LAR, low anterior resection.
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###### 

Permanent stoma as a result of poor healing of leakage stratified by risk factors for anastomotic leakage and type of resection

           n     Anastomotic leakage, n (%)   Permanent stoma as a result of poor healing of leakage, n (%)[a](#ags312033-note-0005){ref-type="fn"}
  -------- ----- ---------------------------- -------------------------------------------------------------------------------------------------------
  Male     199   54 (27.1)                    16 (29.6)
  ≥65 y    94    19 (20.2)                    6 (31.6)
  \<65 y   105   35 (33.3)                    10 (28.6)
  LAR      113   33 (29.2)                    9 (27.3)
  ISR      86    21 (24.4)                    7 (33.3)
  Female   76    6 (7.8)                      0 (0)
  ≥65 y    38    2 (5.3)                      0 (0)
  \<65 y   38    4 (10.5)                     0 (0)
  LAR      44    5 (11.4)                     0 (0)
  ISR      32    1 (3.1)                      0 (0)

Rate in patients with anastomotic leakage.

ISR, intersphincteric resection; LAR, low anterior resection.

John Wiley & Sons, Ltd

3.4. Defecation function and QOL {#ags312033-sec-0011}
--------------------------------

Defecation function was surveyed by mailing a questionnaire to 27 patients who developed anastomotic leakage (response rate: 45.0%) and 116 patients who did not develop anastomotic leakage (response rate: 53.9%). Frequency of defecation per day and Wexner and mFIQL scores were compared for these groups. Comparing the backgrounds of the two groups, the anastomotic leakage group had a significantly higher rate of BMI ≥25 kg/m^2^ (44.4% vs 23.3%), but the median follow‐up periods of 63.5 and 63 months, respectively, and all other clinicopathological factors did not differ significantly between the groups. Median (quartile) frequency of defecation per day and Wexner and mFIQL scores were 4 (1.5‐4), 6 (2.5‐9), and 26.1 (4.8‐64.2), respectively, in patients with anastomotic leakage, and 4 (1.5‐4), 6 (3‐11), and 23.8 (5.9‐60.7), respectively, in those without anastomotic leakage, with no significant differences between the groups (Table [5](#ags312033-tbl-0005){ref-type="table-wrap"}). Gender and resection procedure had no significant effect on anastomotic leakage‐associated defecation function or QOL (Table [5](#ags312033-tbl-0005){ref-type="table-wrap"}).

###### 

Defecation function and QOL stratified by anastomotic leakage

  Responders                 Anastomotic leakage                                 No anastomotic leakage                               *P* value
  -------------------------- --------------------------------------------------- ---------------------------------------------------- -----------
  All responders, n (%)      27 (45.0)[a](#ags312033-note-0008){ref-type="fn"}   116 (53.9)[a](#ags312033-note-0008){ref-type="fn"}   
  Period (mo)                63.5 (43.7‐79.7)                                    63.0 (48.0‐94.0)                                     0.582
  Bowel movements            4.0 (1.5‐4.0)                                       4.0 (1.5‐4.0)                                        0.641
  Wexner score               6.0 (2.5‐9.0)                                       6.0 (3.0‐11.0)                                       0.513
  mFIQL score                26.1 (4.8‐64.2)                                     23.8 (5.9‐60.7)                                      0.719
  Male responders, n (%)     21 (38.8)[a](#ags312033-note-0008){ref-type="fn"}   75 (43.6)[a](#ags312033-note-0008){ref-type="fn"}    
  Bowel movements            4.0 (4.0‐4.0)                                       4.0 (1.5‐4.5)                                        0.556
  Wexner score               5.0 (2.0‐12.0)                                      8.0 (3.0‐12.0)                                       0.256
  mFIQL score                26.2 (7.1‐57.1)                                     33.3 (9.5‐65.5)                                      0.585
  Female responders, n (%)   6 (100)[a](#ags312033-note-0008){ref-type="fn"}     41 (58.5)[a](#ags312033-note-0008){ref-type="fn"}    
  Bowel movements            1.0 (0.5‐5.6)                                       4.0 (0.5‐4.0)                                        0.608
  Wexner score               6.5 (6.0‐8.5)                                       4.0 (2.0‐8.0)                                        0.424
  mFIQL score                14.8 (2.9‐56.2)                                     11.9 (4.8‐38.1)                                      0.86
  LAR responders, n (%)      16 (42.1)[a](#ags312033-note-0008){ref-type="fn"}   68 (57.1)[a](#ags312033-note-0008){ref-type="fn"}    
  Bowel movements            4.0 (3.3‐4.0)                                       4.0 (1.3‐4.0)                                        0.32
  Wexner score               4.0 (0.0‐7.5)                                       4.5 (2.0‐8.0)                                        0.482
  mFIQL score                14.8 (3.6‐39.8)                                     23.8 (6.5‐43.4)                                      1
  ISR responders, n (%)      11 (50.0)[a](#ags312033-note-0008){ref-type="fn"}   48 (50.0)[a](#ags312033-note-0008){ref-type="fn"}    
  Bowel movements            4.0 (1.2‐5.5)                                       4.0 (1.5‐7.0)                                        0.796
  Wexner score               7.0 (5.5‐14.0)                                      9.0 (4.7‐14.0)                                       0.711
  mFIQL score                50.0 (16.6‐69.0)                                    36.9 (4.8‐74.4)                                      1

Data are shown as median (interquartile range).

\% response rate in the respective group.

ISR, intersphincteric resection; LAR, low anterior resection; mFIQL, modified fecal incontinence quality of life; QOL, quality of life.

John Wiley & Sons, Ltd

4. DISCUSSION {#ags312033-sec-0012}
=============

A diverting stoma may contribute to prevention of anastomotic leakage in cases with low anastomosis near the anus, and is generally formed in anus‐preserving surgery for low rectal cancer.[1](#ags312033-bib-0001){ref-type="ref"}, [2](#ags312033-bib-0002){ref-type="ref"}, [3](#ags312033-bib-0003){ref-type="ref"} However, in a recent multicenter study in Japan, a diverting stoma did not reduce the incidence of anastomotic leakage after low anastomosis, but did significantly reduce the rate of reoperation after anastomotic leakage.[4](#ags312033-bib-0004){ref-type="ref"} There was no difference in mortality between patients with and without diverting stoma formation,[4](#ags312033-bib-0004){ref-type="ref"} suggesting that a diverting stoma is unnecessary if anastomotic leakage is treated appropriately, including with reoperation.

As complications associated with diverting stoma formation and stoma closure may develop, this procedure is not necessarily a safe intervention.[16](#ags312033-bib-0016){ref-type="ref"} Therefore, if a diverting stoma does not reduce anastomotic leakage‐ and surgery‐related deaths, patients who are unlikely to develop anastomotic leakage undergo an unnecessary and risky procedure. Therefore, the significance of a diverting stoma requires investigation, including the rate of permanent stoma formation and defecation function. The significance of the present study is that the indication for diverting stoma was investigated based on long‐term anal conditions, defecation function, and QOL as outcomes.

One of the main goals was to identify the perioperative risk factors for permanent stoma in all aspects in consecutive patients with low rectal cancer at a tertiary hospital. We considered that this analysis could offer valuable overview of the consequences after sphincter‐preserving surgery for low rectal cancer without a diverting stoma to patients and physicians. We first identified anastomotic leakage as a risk factor for permanent stoma formation, as previously found.[17](#ags312033-bib-0017){ref-type="ref"}, [18](#ags312033-bib-0018){ref-type="ref"}, [19](#ags312033-bib-0019){ref-type="ref"}, [20](#ags312033-bib-0020){ref-type="ref"}, [21](#ags312033-bib-0021){ref-type="ref"} Age \<65 years and male gender were then identified as independent risk factors for anastomotic leakage. A permanent stoma was formed as a result of poor healing of anastomotic leakage in one in three males, regardless of age and resection procedure. In contrast, in females, the incidence of anastomotic leakage was low and there was no permanent stoma formation as a result of poor healing of anastomotic leakage.

Reduction of defecation function is of concern when anastomotic leakage occurs, but findings have varied among previous studies.[22](#ags312033-bib-0022){ref-type="ref"}, [23](#ags312033-bib-0023){ref-type="ref"}, [24](#ags312033-bib-0024){ref-type="ref"} In our patients, anastomotic leakage did not contribute to reduction of long‐term defecation function and QOL, and there was no influence of sex or resection procedure. Thus, in female patients, sphincter‐preserving surgery for low rectal cancer without diverting stoma formation is unlikely to have a negative influence on permanent stoma formation as a result of poor healing of anastomotic leakage and reduced long‐term defecation function and QOL. In a study of short‐term anastomotic leakage following diverting stoma formation after low anastomosis, a diverting stoma was found to be useful in males, but not in females.[25](#ags312033-bib-0025){ref-type="ref"} The long‐term anal function in our study supports the validity of low anastomosis without diverting stoma formation after rectal resection in female patients. As there is no clear basis for expecting long‐term improvement of defecation function and QOL by accepting reduction of QOL as a result of diverting stoma formation, a diverting stoma should be formed only in cases in which it is likely to be beneficial.

The incidence of anastomotic leakage was high in our patients, but mortality was low, suggesting that appropriate treatment was carried out. However, strategies to prevent anastomotic leakage are necessary.[26](#ags312033-bib-0026){ref-type="ref"} Many factors influence anastomotic leakage, but male gender is a common risk factor in many reports, but no specific countermeasures for males have been developed.[2](#ags312033-bib-0002){ref-type="ref"}, [4](#ags312033-bib-0004){ref-type="ref"}, [25](#ags312033-bib-0025){ref-type="ref"}, [27](#ags312033-bib-0027){ref-type="ref"}, [28](#ags312033-bib-0028){ref-type="ref"}, [29](#ags312033-bib-0029){ref-type="ref"} Diverting stoma formation has been proposed, but it is uncertain if this approach reduces the incidence of anastomotic leakage.[4](#ags312033-bib-0004){ref-type="ref"}, [25](#ags312033-bib-0025){ref-type="ref"} A low incidence of anastomotic leakage has been reported in laparoscopic surgery, and we have introduced laparoscopic rectal resection and attempted to improve the quality of the operation by pursuing the Japan Society for Endoscopic Surgery (JSES) technical qualifications. Reduction of the incidence of anastomotic leakage is expected with improvement of the surgical technique,[30](#ags312033-bib-0030){ref-type="ref"} but male gender is still a risk factor for anastomotic leakage after laparoscopic surgery.[29](#ags312033-bib-0029){ref-type="ref"}, [31](#ags312033-bib-0031){ref-type="ref"} In addition to the improvement of surgical quality, a new strategy such as transanal approach with intraoperative blood perfusion assessment might offer safe sphincter‐preserving surgery to patients at high risk of anastomotic leakage.[32](#ags312033-bib-0032){ref-type="ref"}, [33](#ags312033-bib-0033){ref-type="ref"} Given the high incidence of anastomotic leakage and high rate of permanent stoma formation as a result of poor healing after anastomotic leakage in male patients in the current study, it may be desirable to form a diverting stoma in males until identification of reliable predictors of a low risk of anastomotic leakage after low anastomosis. For patients with risk factors of local recurrence, the introduction of preoperative adjuvant therapy and precise assessment of tumor extension by high‐resolution magnetic resonance imaging (MRI) could offer oncological safe sphincter‐preserving surgery and justify inevitable abdominoperineal resection.[34](#ags312033-bib-0034){ref-type="ref"}

There are several limitations in the present study. First, it was carried out as a single‐center retrospective observational study, and only a small number of patients treated with currently accepted laparoscopic surgery were included. The high rate of anastomotic leakage in this single center suggested that there might have been some technical problems which could be a limitation of this study. Second, only about 50% of patients responded to the questionnaire on evaluation of anal function, and the presence of a bias as a result of non‐respondents cannot be ruled out. Third, the subjects were patients who did not receive preoperative treatment. Such treatment for low rectal cancer is not specified as a standard approach in current Japanese guidelines, but preoperative chemoradiotherapy is standard treatment in Western countries.[35](#ags312033-bib-0035){ref-type="ref"} Our institution has formed a diverting stoma in patients treated with preoperative radiotherapy based on poor healing of the anastomosis region, and a diverting stoma may be significant for prevention of anastomotic leakage in female patients treated with preoperative radiotherapy.[36](#ags312033-bib-0036){ref-type="ref"} In contrast, favorable local outcomes have been reported in Europe for rectal cancer treated with surgery alone without preoperative treatment, with selection of patients based on preoperative high‐resolution MRI.[37](#ags312033-bib-0037){ref-type="ref"} Patients similar to the subjects in the current study are likely to increase worldwide, and thus our results may be significant, despite the above limitations.

5. CONCLUSIONS {#ags312033-sec-0013}
==============

Sphincter‐preserving surgery for low rectal cancer without diverting stoma formation may be indicated for female patients. Male gender was a risk factor for anastomotic leakage in this procedure, with a permanent stoma as a result of anastomotic leakage formed in one in three male patients.
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